129 related articles for article (PubMed ID: 24122844)
1. Incidence and survival patterns of cranial chordoma in the United States.
Chambers KJ; Lin DT; Meier J; Remenschneider A; Herr M; Gray ST
Laryngoscope; 2014 May; 124(5):1097-102. PubMed ID: 24122844
[TBL] [Abstract][Full Text] [Related]
2. Outcomes and patterns of care in adult skull base chordomas from the Surveillance, Epidemiology, and End Results (SEER) database.
Jones PS; Aghi MK; Muzikansky A; Shih HA; Barker FG; Curry WT
J Clin Neurosci; 2014 Sep; 21(9):1490-6. PubMed ID: 24852903
[TBL] [Abstract][Full Text] [Related]
3. Incidence and relative survival of chordomas: the standardized mortality ratio and the impact of chordomas on a population.
Smoll NR; Gautschi OP; Radovanovic I; Schaller K; Weber DC
Cancer; 2013 Jun; 119(11):2029-37. PubMed ID: 23504991
[TBL] [Abstract][Full Text] [Related]
4. Chordoma: incidence and survival patterns in the United States, 1973-1995.
McMaster ML; Goldstein AM; Bromley CM; Ishibe N; Parry DM
Cancer Causes Control; 2001 Jan; 12(1):1-11. PubMed ID: 11227920
[TBL] [Abstract][Full Text] [Related]
5. Sinonasal adenoid cystic carcinoma: comprehensive analysis of incidence and survival from 1973 to 2009.
Sanghvi S; Patel NR; Patel CR; Kalyoussef E; Baredes S; Eloy JA
Laryngoscope; 2013 Jul; 123(7):1592-7. PubMed ID: 23553267
[TBL] [Abstract][Full Text] [Related]
6. Polymorphous low-grade adenocarcinoma of the head and neck: A population-based study of 460 cases.
Patel TD; Vazquez A; Marchiano E; Park RC; Baredes S; Eloy JA
Laryngoscope; 2015 Jul; 125(7):1644-9. PubMed ID: 25877006
[TBL] [Abstract][Full Text] [Related]
7. Analysis of prognostic factors for survival in patients with primary spinal chordoma using the SEER Registry from 1973 to 2014.
Pan Y; Lu L; Chen J; Zhong Y; Dai Z
J Orthop Surg Res; 2018 Apr; 13(1):76. PubMed ID: 29625617
[TBL] [Abstract][Full Text] [Related]
8. Cranial base chordoma--long term outcome and review of the literature.
Yoneoka Y; Tsumanuma I; Fukuda M; Tamura T; Morii K; Tanaka R; Fujii Y
Acta Neurochir (Wien); 2008 Aug; 150(8):773-8; discussion 778. PubMed ID: 18548191
[TBL] [Abstract][Full Text] [Related]
9. Malignant head and neck paragangliomas: treatment efficacy and prognostic indicators.
Sethi RV; Sethi RK; Herr MW; Deschler DG
Am J Otolaryngol; 2013; 34(5):431-8. PubMed ID: 23642313
[TBL] [Abstract][Full Text] [Related]
10. Head and neck rhabdomyosarcoma: a critical analysis of population-based incidence and survival data.
Turner JH; Richmon JD
Otolaryngol Head Neck Surg; 2011 Dec; 145(6):967-73. PubMed ID: 21873599
[TBL] [Abstract][Full Text] [Related]
11. [Chordomas. Analysis of 24 cases].
Danilewicz M; Czepko R; Stachura K; Melanowska-Danilewicz E; Radkowski A
Przegl Lek; 1999; 56(2):115-8. PubMed ID: 10375941
[TBL] [Abstract][Full Text] [Related]
12. Five-year survival rates and time trends of laryngeal cancer in the US population.
Cosetti M; Yu GP; Schantz SP
Arch Otolaryngol Head Neck Surg; 2008 Apr; 134(4):370-9. PubMed ID: 18427002
[TBL] [Abstract][Full Text] [Related]
13. Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database.
Carvalho AL; Nishimoto IN; Califano JA; Kowalski LP
Int J Cancer; 2005 May; 114(5):806-16. PubMed ID: 15609302
[TBL] [Abstract][Full Text] [Related]
14. Descriptive epidemiology of chordomas in the United States.
Das P; Soni P; Jones J; Habboub G; Barnholtz-Sloan JS; Recinos PF; Kshettry VR
J Neurooncol; 2020 May; 148(1):173-178. PubMed ID: 32342333
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive Review of Cranial Chordomas Using National Databases in the USA.
Hulou MM; Garcia CR; Slone SA; Dugan A; Lei F; Huang B; Pittman T; Villano JL
Clin Oncol (R Coll Radiol); 2019 Sep; 31(9):e149-e159. PubMed ID: 31303332
[TBL] [Abstract][Full Text] [Related]
16. Pediatric head and neck malignancies: incidence and trends, 1973-2010.
Schwartz I; Hughes C; Brigger MT
Otolaryngol Head Neck Surg; 2015 Jun; 152(6):1127-32. PubMed ID: 25820588
[TBL] [Abstract][Full Text] [Related]
17. Clinical findings in families with chordoma with and without T gene duplications and in patients with sporadic chordoma reported to the Surveillance, Epidemiology, and End Results program.
Parry DM; McMaster ML; Liebsch NJ; Patronas NJ; Quezado MM; Zametkin D; Yang XR; Goldstein AM
J Neurosurg; 2020 Jun; 134(5):1399-1408. PubMed ID: 32559743
[TBL] [Abstract][Full Text] [Related]
18. Presentation, Treatment, and Long-Term Outcome of Intrasellar Chordoma: A Pooled Analysis of Institutional, SEER (Surveillance Epidemiology and End Results), and Published Data.
Ahmed AK; Dawood HY; Arnaout OM; Laws ER; Smith TR
World Neurosurg; 2018 Jan; 109():e676-e683. PubMed ID: 29061463
[TBL] [Abstract][Full Text] [Related]
19. Progression of mean age and mean expected mortality rate by duration of follow up in cohorts with a wide range of age.
Singer RB
J Insur Med; 2006; 38(3):181-91. PubMed ID: 17076138
[TBL] [Abstract][Full Text] [Related]
20. Radiation therapy for chordomas of the base of skull and cervical spine: patterns of failure and outcome after relapse.
Fagundes MA; Hug EB; Liebsch NJ; Daly W; Efird J; Munzenrider JE
Int J Radiat Oncol Biol Phys; 1995 Oct; 33(3):579-84. PubMed ID: 7558946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
